PD01-03 THIRD INTERIM ANALYSIS (IA3) OF THE DAROLUTAMIDE OBSERVATIONAL (DAROL) STUDY IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC).

Autor:	Gotto, Geoffrey, Suzuki, Hiroyoshi, Luz, Murilo, Briganti, Alberto, Yu, Evan Y., Pieczonka, Christopher, Murphy, Declan, Malone, Ryan, Hamilton, Joelle, Chan, Jonathan E., Sieber, Paul, Given, Robert W., Adorjan, Patrick, Ghadessi, Mercedeh, Verholen, Frank, Armstrong, Andrew J.
Předmět:	CASTRATION-resistant prostate cancer
Zdroj:	Journal of Urology; 2024 Supplement 5, Vol. 211, pe63-e63, 1p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu